Selleckchem Inc

Bio Active Compounds.

Recent products

Pimivalimab (Anti-PDCD1 / PD-1 / CD279)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Pidilizumab (Anti-PDCD1 / PD-1 / CD279)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Penpulimab (Anti-PDCD1 / PD-1 / CD279)

Price range: £221.00 through £1,941.00 / 309.402,717.40 Standard

Ezabenlimab (Anti-PDCD1 / PD-1 / CD279)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Cetrelimab (Anti-PDCD1 / PD-1 / CD279)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Budigalimab (Anti-PDCD1 / PD-1 / CD279)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Balstilimab (Anti-PDCD1 / PD-1 / CD279)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-ASIC1

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-PCSK9 (RG7652)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Recaticimab (Anti-PCSK9)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Ralpancizumab (Anti-PCSK9)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Quavonlimab (Anti-CTLA-4 / CD152)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-MRC2 / CD280

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Prolgolimab (Anti-PDCD1 / PD-1 / CD279)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-PCLA

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Pozelimab (Anti-Complement C5)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

1 657 658 659 705